Literature DB >> 23551726

Hormones other than aldosterone may contribute to hypertension in 3 different subtypes of primary aldosteronism.

Fei Ye1, Zheng-Yi Tang, Jing-Cheng Wu, Yang Yang, Xiu-Li Tian, Jia-Jia Huang, Shan-Shan Zhang, Guang Ning.   

Abstract

Blood pressure (BP) level is similar in patients with 3 subtypes of primary aldosteronism (PA), even though aldosterone levels may vary. Glucocorticoids and adrenomedullary hormones may be influenced and may contribute to hypertension in PA. The authors' objective was to investigate the influence of PA on adrenal gland secretion and the roles of these hormones in hypertension. Patients diagnosed with PA (229 cases) were enrolled and classified into 3 subgroups: aldosterone-producing adenoma (APA), unilateral nodular adrenal hyperplasia (UNAH), and idiopathic hyperaldosteronism (IHA). Patients with essential hypertension served as the control group (100 cases). Concentration of the above hormones was measured and compared between groups. Level of plasma adrenocorticotrophic hormone (ACTH) in patients with APA was significantly lower than that in patients with IHA (P<.001) and UNAH (P<0.5). The 24-hour urinary free cortisol and adrenomedullary hormone levels were highest in patients with IHA, lower in patients with APA, and lowest in patients with UNAH. Systolic BP level was positively correlated with 8 am plasma cortisol level (r=0.142, P=.039) and plasma ACTH level (r=0.383, P=.016). Cortisol and adrenomedullary hormones were different between PA subtypes and they might involve regulation of BP in those patients.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23551726      PMCID: PMC8033846          DOI: 10.1111/jch.12070

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

1.  Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.

Authors:  Gian Paolo Rossi; Anna Belfiore; Giampaolo Bernini; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Domenico Montemurro; Gaetana Palumbo; Damiano Rizzoni; Ermanno Rossi; Andrea Semplicini; Enrico Agabiti-Rosei; Achille Cesare Pessina; Franco Mantero
Journal:  J Hypertens       Date:  2007-07       Impact factor: 4.844

2.  Prevalence and characteristics of the metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Franco Veglio; Chiara Bertello; Nicoletta Sonino; Paolo Della Mea; Mario Ermani; Franco Rabbia; Giovanni Federspil; Paolo Mulatero
Journal:  J Clin Endocrinol Metab       Date:  2005-11-15       Impact factor: 5.958

3.  Renal damage in primary aldosteronism: results of the PAPY Study.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Massimo Mannelli; Mee-Jung Matterello; Domenico Montemurro; Gaetana Palumbo; Damiano Rizzoni; Ermanno Rossi; Achille Cesare Pessina; Franco Mantero
Journal:  Hypertension       Date:  2006-06-26       Impact factor: 10.190

4.  Spironolactone as a nonspecific treatment for primary aldosteronism.

Authors:  E L Bravo; H P Dustan; R C Tarazi
Journal:  Circulation       Date:  1973-09       Impact factor: 29.690

5.  Optimisation of antihypertensive treatment by crossover rotation of four major classes.

Authors:  J E Dickerson; A D Hingorani; M J Ashby; C R Palmer; M J Brown
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

6.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.

Authors:  Gian Paolo Rossi; Giampaolo Bernini; Chiara Caliumi; Giovambattista Desideri; Bruno Fabris; Claudio Ferri; Chiara Ganzaroli; Gilberta Giacchetti; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Massimo Mannelli; Mee-Jung Mattarello; Angelica Moretti; Gaetana Palumbo; Gabriele Parenti; Enzo Porteri; Andrea Semplicini; Damiano Rizzoni; Ermanno Rossi; Marco Boscaro; Achille Cesare Pessina; Franco Mantero
Journal:  J Am Coll Cardiol       Date:  2006-11-13       Impact factor: 24.094

7.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study.

Authors:  Joanna Matrozova; Olivier Steichen; Laurence Amar; Sabina Zacharieva; Xavier Jeunemaitre; Pierre-François Plouin
Journal:  Hypertension       Date:  2009-02-16       Impact factor: 10.190

Review 9.  Primary aldosteronism: part II: subtype differentiation and treatment.

Authors:  G P Rossi; T M Seccia; A C Pessina
Journal:  J Nephrol       Date:  2008 Jul-Aug       Impact factor: 3.902

10.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

Authors:  John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-06-13       Impact factor: 5.958

View more
  3 in total

1.  Beauty in Simplicity: Abnormal Neutrophil to Lymphocyte Ratio in Resistant Hypertension.

Authors:  Tibor Fülöp; Mihály Tapolyai
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-23       Impact factor: 3.738

2.  Primary aldosteronism during long-term ulcerative colitis: a diagnostic challenge.

Authors:  John K Triantafillidis; George Malgarinos; Achilleas Rentis; Konstantinos Vagianos
Journal:  Ann Gastroenterol       Date:  2014

3.  Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas.

Authors:  Hiroki Kobayashi; Akira Haketa; Ueno Takahiro; Hiromasa Otsuka; Sho Tanaka; Yoshinari Hatanaka; Yukihiro Ikeda; Masanori Abe; Noboru Fukuda; Masayoshi Soma
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-12-05       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.